Cargando…

REGEN-Cov antibody combination to prevent COVID-19 infection in kidney transplant recipient without detectable antibody response to optimal vaccine scheme

Detalles Bibliográficos
Autores principales:	Ducloux, Didier, Courivaud, Cécile
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724020/ https://www.ncbi.nlm.nih.gov/pubmed/34995651 http://dx.doi.org/10.1016/j.kint.2021.12.015

Ejemplares similares

Should vaccination against COVID-19 be mandated in patients on the transplant waiting list?
por: Ducloux, Didier, et al.
Publicado: (2021)

Triglyceride-Glucose Index and Cardiovascular Events in Kidney Transplant Recipients
por: Colladant, Mathilde, et al.
Publicado: (2023)

Prevention of Post-Transplant Diabetes Mellitus: Towards a Personalized Approach
por: Ducloux, Didier, et al.
Publicado: (2022)

Factors associated with humoral response after BNT162b2 mRNA COVID-19 vaccination in kidney transplant patients
por: Ducloux, Didier, et al.
Publicado: (2021)

Current vaccine strategies against SARS_CoV-2 only poorly protect kidney transplant recipients
por: DUCLOUX, Didier, et al.
Publicado: (2022)

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Pre-transplant Thymic Function Predicts Is Associated With Patient Death After Kidney Transplantation
por: Courivaud, Cécile, et al.
Publicado: (2020)

Humoral response after BNT162b2 mRNA COVID-19 vaccination in patients on haemodialysis depends on immune status
por: Ducloux, Didier, et al.
Publicado: (2021)

Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
por: Ducloux, Didier, et al.
Publicado: (2021)

True effect of monoclonal antibody for COVID-19 in kidney transplant recipients
por: Khatri, Akshay, et al.
Publicado: (2022)

Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
por: Chavarot, Nathalie, et al.
Publicado: (2022)

Conversion From Belatacept to Another Immunosuppressive Regimen in Maintenance Kidney-Transplantation Patients
por: Gouin, Anna, et al.
Publicado: (2020)

Determinants of urgent start dialysis in a chronic kidney disease cohort followed by nephrologists
por: Tachikart, Amin, et al.
Publicado: (2023)

Pre-transplant immune profile defined by principal component analysis predicts acute rejection after kidney transplantation
por: Gaiffe, Emilie, et al.
Publicado: (2023)

Decline and loss of anti–SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection
por: Chavarot, Nathalie, et al.
Publicado: (2021)

Efficacy of anti–SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients
por: Bertrand, Dominique, et al.
Publicado: (2022)

Transfused Red Blood Cell Characteristics and Kidney Transplant Outcomes Among Patients Receiving Early Posttransplant Transfusion
por: Gaiffe, Emilie, et al.
Publicado: (2023)

Neutralization of SARS-CoV-2 Omicron and Delta Variants in Relation to Vaccine-Induced Antibody Levels in Kidney Transplant Recipients and Healthy Controls
por: Pedersen, Rune M., et al.
Publicado: (2022)

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
por: O’Brien, Meagan P., et al.
Publicado: (2021)

Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention
por: O’Brien, Meagan P., et al.
Publicado: (2021)

The Interleukin-6 Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients
por: Bamoulid, Jamal, et al.
Publicado: (2011)

Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination
por: Matsunami, Masatoshi, et al.
Publicado: (2022)

Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients
por: Boyarsky, Brian J., et al.
Publicado: (2021)

Antibody response to a third dose of SARS‐CoV‐2 vaccine in heart and lung transplant recipients
por: Alejo, Jennifer L., et al.
Publicado: (2022)

Breakthrough omicron COVID-19 infections in patients receiving the REGEN-Cov antibody combination
por: Flahault, Adrien, et al.
Publicado: (2022)

Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study
por: Gaiffe, Emilie, et al.
Publicado: (2022)

Increased Complement Gene Expression in Circulating B Cells From Kidney Transplant Recipients With Chronic Antibody-Mediated Rejection
por: Cravedi, Paolo, et al.
Publicado: (2022)

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients
por: Bertrand, Dominique, et al.
Publicado: (2021)

Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients
por: Gueguen, Juliette, et al.
Publicado: (2022)

Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection
por: Crespo, Marta, et al.
Publicado: (2021)

Reversible Fluindione-Induced Chronic Interstitial Nephritis
por: Crepin, Thomas, et al.
Publicado: (2016)

End-Stage Renal Disease-Related Accelerated Immune Senescence: Is Rejuvenation of the Immune System a Therapeutic Goal?
por: Ducloux, Didier, et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patients
por: Bertrand, Dominique, et al.
Publicado: (2021)

Postvaccine Anti–SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients
por: Husain, Syed Ali, et al.
Publicado: (2021)

500. Durability of antibody response after booster vaccination against SARS-CoV-2 in kidney transplant recipients with or without prior infection
por: Ueaphongsukkit, Thornthun, et al.
Publicado: (2023)

Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant Recipients
por: Bachmann, Friederike, et al.
Publicado: (2022)

Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes
por: Hayek, Samah, et al.
Publicado: (2022)

Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
por: De Greef, Julien, et al.
Publicado: (2021)

Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated Atherosclerosis
por: Ducloux, Didier, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_86aec4d8egs49iuq1ga2rdeqfn